New therapies for early Alzheimer's disease, monoclonal antibodies that remove amyloid-β plaques in the brain, are bringing hope to people whose lives have been affected by the disease. To help neurologists discuss these therapies with patients and caregivers, the American Academy of Neurology has...
Introduction: Current pharmacological recommendations for the treatment of Alzheimer's disease (AD) include the cholinesterase inhibitors and the N-methyl-D-aspartate antagonist, memantine. However, these medications only manage symptoms of AD, and do not target A beta plaques and neurofibrillary tangles...
Facilitating early Alzheimer’s diagnosis Araclon Biotech has also developed two plasma CE-marked tests to predict the risk of Alzheimer’s. Through mass spectrometry (ABtest-MS) and the ELISA technique (ABtest-IA), the tests quantify accurately and robustly the levels of Ab42 and Ab40 found...
Improving awareness of the burden of Alzheimer's disease on patients, caregivers and the health care system; Reducing barriers to early diagnosis; and Increasing understanding of Alzheimer's disease stages and the window for amyloid-reducing therapies. Expert Panelists:...
New Data from Biogen’s Investigational Antisense Oligonucleotide (ASO) Targeting Tau Shows Promise for Potential New Generation of Treatments in Early Alzheimer’s Disease October 25, 2023 PDF Version In the Phase 1b study, favorable trends were reported for the high-dose gr...
Currently, some medicines can slow the progression of Alzheimer's, but no treatment can completely stop the process or reverse it. Vascular dementia Vascular contributions to cognitive impairment and dementia (VCID) is caused by the same risk factors that increase your risk for stroke, such as ...
Currently, some medicines can slow the progression of Alzheimer's, but no treatment can completely stop the process or reverse it. Vascular dementia Vascular contributions to cognitive impairment and dementia (VCID) is caused by the same risk factors that increase your risk for stroke, such as ...
Here’s how you may get it (but we’re not sure): Feces. Officials are recommending that anyone in your house with the virus use their own bathroom—if possible—to reduce potential infection of others in the house. Early research seems to indicate that the virus is “shed,” or release...
The BetterHelp platform is not intended for any information regarding which drugs, medication, or medical treatment may be appropriate for you. The content provides generalized information that is not specific to one individual. You should not take any action without consulting a qualified medical prof...
Moreover, MSCs are easily expandable in vitro and hence MSCs are used in many clinical trials targeting a huge range of diseases and conditions from neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease, autoimmune disease such as multiple sclerosis to injury conditions such...